Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris

被引：0
|
作者：
Cartwright, Martina [1 ]
Moro, Luigi [2 ]
Fragasso, Enrico [2 ]
机构：
[1] Cassiopea Inc, San Diego, CA USA
[2] Cassiopea SpA, Lainate, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34781
引用
收藏
页码：AB49 / AB49
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of 1% clascoterone cream in patients ≥12 years old with acne vulgaris
    Eichenfield, Lawrence
    Hebert, Adelaide
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 4 - 4
  • [2] Long-term safety and efficacy of 1% clascoterone cream in patients <12 years old with acne vulgaris
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB190 - AB190
  • [3] Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients ≥12 years of Age With Acne Vulgaris
    Eichenfield, Lawrence F.
    Gold, Linda Stein
    Han, Jenny
    Hebert, Adelaide A.
    Mazzetti, Alessandro
    Moro, Luigi
    Squittieri, Nicholas
    Thiboutot, Diane
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (01) : 1278 - 1283
  • [4] EFFICACY OF CLASCOTERONE CREAM 1% FOR UP TO 12 MONTHS IN PATIENTS $9 YEARS OF AGE WITH ACNE VULGARIS: RESULTS FROM A LONG-TERM EXTENSION STUDY
    Eichenfield, L. F.
    Hebert, A. A.
    Gold, Stein L.
    Cartwright, M.
    Moro, L.
    Han, J.
    Squittieri, N.
    Mazzetti, A.
    VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [5] EFFICACY AND SAFETY OF CLASCOTERONE CREAM 1% IN PATIENTS WITH ACNE VULGARIS ACROSS SUBGROUPS DEFINED BY DEMOGRAPHIC CHARACTERISTICS
    Eichenfield, L. F.
    Hebert, A. A.
    Stein, Gold L.
    Cartwright, M.
    Moro, L.
    Han, J.
    Squittieri, N.
    Mazzetti, A.
    VALUE IN HEALTH, 2023, 26 (06) : S29 - S29
  • [6] Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics
    Eichenfield, Lawrence
    Hebert, Adelaide
    Thiboutot, Diane
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 4 - 5
  • [7] Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Thiboutot, Diane
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB41 - AB41
  • [8] Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
    Mazzetti, Alessandro
    Kyeremateng, Kizito
    Moro, Luigi
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3651 - 3652
  • [9] Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
    Sanchez, Carol
    Keri, Jonette
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1357 - 1366
  • [10] Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older
    Gold, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (04) : 301 - 308
12345